BRD5631
Based on 1 publication(s) in Google Scholar
BRD5631 is an autophagy enhancer, enhances autophagy through an mTOR-independent pathway. BRD5631 affects several cellular disease phenotypes previously linked to autophagy, including protein aggregation, cell survival, bacterial replication, and inflammatory cytokine production.
For research use only. We do not sell to patients.
- CAS No.: 2446154-91-0
- Formula: C30H35N3O4
- Molecular Weight:501.62
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) BRD5631
More-
IF
-
IF
Biological Activity
Autophagy[1]
BRD5631 (10 μM, 48 hours) leads to increased levels of LC3-II in HeLa cells. BRD5631 stimulates formation of new autophagosomes, which is consistent with its ability to increase numbers of autolysosomes in the mCherry-GFP-LC3 assay[1].
BRD5631 does not enhance autophagy by directly inhibiting mTOR or the mTOR signaling pathway. BRD5631 suppressed IL-1β secretion in an autophagy-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HeLa cells.
-
Concentration:10 μM.
-
Incubation Time:48 hours.
-
Result:Led to increased levels of LC3-II.
Chemical Information
-
CAS No. 2446154-91-0
-
Molecular Weight 501.62
-
Formula C30H35N3O4
-
SMILES
O=C(NC1=CC=C2C(C(N(C[C@@H](OC)[C@@H](C)CN[C@@H](C)CO2)C)=O)=C1)C3=CC=C(C4=CC=CC=C4)C=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Cancer Gene Ther
miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2. [Abstract]2023 Apr;30(4):596-607. PMID: 36494581
BRD5631 purchased from MedChemExpress. Usage Cited in: Cancer Gene Ther. 2023 Apr;30(4):596-607. [Abstract]
Both HLY78 and BRD5631 significantly abrogate the effects of miR-219-5p on SKOV3 and SKOV3/DDP cell invasion (fig E) and migration (fig F).
BRD5631 purchased from MedChemExpress. Usage Cited in: Cancer Gene Ther. 2023 Apr;30(4):596-607. [Abstract]
Both HLY78 and BRD5631 significantly abrogate the effect of miR-219-5p on SKOV3 and SKOV3/DDP cell apoptosis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)